Statera Biopharma (NASDAQ:STAB) Prices Public Offering: Stock Tanks

March 25, 2022

In the past week, the Statera Biopharma (NASDAQ:STAB) stock has declined sharply amidst a heavy selloff and dived by as much as 45%. Considering the sheer magnitude of the decline in the Statera stock, it may be a good idea for investors to perhaps figure out if the free fall is going to continue or if there is going to be any recovery any time soon. Trading Data On Thursday,…